SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 272.66 |
| Enterprise Value ($M) | 442.43 |
| Book Value ($M) | -171.95 |
| Book Value / Share | -1.78 |
| Price / Book | -1.59 |
| NCAV ($M) | -188.02 |
| NCAV / Share | -1.94 |
| Price / NCAV | -1.45 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.75 |
| Return on Assets (ROA) | -0.45 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.68 |
| Current Ratio | 4.92 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 333.00 |
| Assets | 349.08 |
| Liabilities | 521.02 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Prosight Management, LP | 9.96 | 48.75 | |
| 13G | Oaktree Capital Group Holdings GP, LLC | 5.19 | ||
| 13D/A | Auven Therapeutics Holdings Lp | 2.70 | -64.37 | |
| 13G/A | Redmile Group, LLC | 18.80 | 13.00 | |
| 13G/A | Astrazeneca Plc | 4.88 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 93,330 | 420,576 | 22.19 | |
| 75,308 | 545,464 | 13.81 | |
| 93,159 | 589,227 | 15.81 | |
| 82,566 | 432,986 | 19.07 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABBV – AbbVie Inc. | ABT – Abbott Laboratories |
| ANRO – Alto Neuroscience, Inc. | ANVS – Annovis Bio, Inc. |
Financial data and stock pages provided by
Fintel.io